chungju’s Bold move: Free HPV Vaccines for Young Women Sparks National Debate
A Local Initiative with National Implications
chungju City is making waves with its groundbreaking decision to offer free HPV vaccines to all women aged 18-26, a first in South Korea.Spearheaded by the city’s innovative public relations figure,Kim Sun-tae,known as “Chungju Man,” this initiative aims to broaden the scope of HPV prevention beyond the current national programme,which primarily targets girls aged 12-17 adn low-income women in the 18-26 age bracket.
The proclamation, delivered with Kim Sun-tae’s signature flair, has resonated widely, with the promotional video garnering over 1.5 million views on YouTube. The public response has been overwhelmingly positive, with many calling for the program to be expanded nationwide and advocating for the inclusion of men in HPV vaccination efforts.
The Cost of prevention: A Barrier to Access
Currently, adults seeking HPV vaccination face a significant financial burden, with the full three-dose course costing around ₩600,000 (approximately $450 USD). Chungju’s initiative directly addresses this barrier, potentially setting a precedent for other local governments and influencing national policy.
An official from Chungju City stated,Other local governments are also inquiring about related inquiries.
HPV: A Threat to Both Men and Women
Human papillomavirus (HPV) is primarily transmitted through sexual contact and is responsible for a range of cancers, including cervical cancer, head and neck cancers, and cancers of the anal and reproductive organs. Experts emphasize that vaccinating both men and women is crucial for maximizing prevention efforts. This is reflected in the growing number of countries that include both genders in their national HPV vaccination programs.
As of 2024, 86 countries worldwide have implemented national immunization programs (NIP) that provide HPV vaccines to both males and females.
Political Promises and Unfulfilled Potential
During the previous presidential election,candidates from the opposition party pledged to extend HPV vaccination to males. Former President Yoon Seok-yeol also promised male vaccinations as part of his campaign. Though, this initiative lost momentum following his impeachment. Currently, the Korea Centers for Disease Control and Prevention’s (KCDC) NIP only supports the 4-valent HPV vaccine.
There are three types of HPV vaccines available: 2-valent, 4-valent, and 9-valent. The higher the number, the more HPV types the vaccine protects against. Last year, the National Assembly’s Health and Welfare Committee proposed increasing the NIP budget to upgrade to the 9-valent vaccine and expand vaccination to 12-year-old boys, but this proposal was ultimately excluded from the final budget.
An official from the Korea Centers for Disease Control and Prevention stated, It is necessary to discuss it again when the budget is prepared next year.
expert opinion: The Global Standard
Lee Se-young, a professor of otolaryngology at Chung-Ang University Hospital, emphasizes the preventability of HPV-related cancers through vaccination.
Unlike other cancers with other cancers, cancer caused by HPV can be prevented through vaccines.
Lee Se-young, Professor of Otolaryngology, Chung-Ang University Hospital
Professor Lee also highlights that a significant majority of OECD member countries support HPV vaccination for both men and women.
More than 30 of the 38 countries in the OECD member countries support the vaccination of both men and women.
Lee Se-young, Professor of Otolaryngology, Chung-Ang University Hospital
